Electromed (ELMD) Free Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Electromed (ELMD) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -14.34% |
| 10 | Electromed | 222.94 Mn | 202.49 Mn | 15.28 Mn | -25.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.28% |
| Mar 31, 2026 | 49.48% |
| Dec 31, 2025 | -16.38% |
| Sep 30, 2025 | -105.77% |
| Jun 30, 2025 | -16.86% |
| Mar 31, 2025 | 75.91% |
| Dec 31, 2024 | -14.18% |
| Sep 30, 2024 | 743.63% |
| Jun 30, 2024 | 680.94% |
| Mar 31, 2024 | 1,030.36% |
| Dec 31, 2023 | 270.37% |
| Sep 30, 2023 | 81.76% |
| Jun 30, 2023 | 148.31% |
| Mar 31, 2023 | 136.13% |
| Dec 31, 2022 | 398.91% |
| Sep 30, 2022 | -141.57% |
| Jun 30, 2022 | -307.36% |
| Mar 31, 2022 | -139.64% |
| Dec 31, 2021 | -70.84% |
| Sep 30, 2021 | -199.38% |